Cognos Therapeutics is a medical device company that develops diagnostic and drug delivery devices designed to detect diseases and deliver drugs. The company's devices radically advance the diagnosis and treatment of neuropathic diseases including tumor-based brain and spinal cancers, degenerative cognition disorders, cerebral trauma occurrences, and other Central Nervous System afflictions that enable doctors to detect diseases, monitor their patients, and deliver medicines as per requirements.
Cognos Therapeutics was established in 2003 and is headquartered in Inglewood, California.